VIVA LA RESISTANCE
[Wellness]
June 26, 2024
Scientists have created a drug that induces self-destruction of cancer cells. In Hong Kong, researchers have developed a drug for the treatment of nasopharyngeal cancer. It destroys mutating cells and interacts with immune cells to enhance their fighting capabilities. The invention has shown promising results during trials on mice. Developers note that the drug surpasses its counterparts as it minimizes the consequences for healthy cells. The drug specifically targets cells infected with the Epstein-Barr virus, which is linked to the formation of nasopharyngeal tumors. Another risk factor is smoking.